Ledger.Open graph →
SEC Form D · Amendment · filed May 6, 2024

Endo, Inc

Offering
$170.6M
Sold
$170.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Malvern, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Frank Raciti · Malvern, PAExecPatrick Barry · Malvern, PAExecMatthew Maletta · Malvern, PAExecMark Bradley · Malvern, PAExec · DirectorScott Hirsch · Morristown, NJDirectorMark Bradley · Malvern, PAExec · DirectorFrank Raciti · Malvern, PAExecPatrick Barry · Malvern, PAExecMatthew Maletta · Malvern, PAExecPaul Efron · Boston, MADirectorPaul Herendeen · Malvern, PADirectorMarc Yoskowitz · Malvern, PADirectorBlaise Coleman · Malvern, PAExec · DirectorSophia Langlois · Malvern, PADirectorAndy Pasternak · Malvern, PADirectorRuss E. Mcatee · Hawthorne, CAExecMalachy T. Coghlan · Hawthorne, CAExecShannon E. Doiron · Hawthorne, CAExecRick P. Thompson · Hawthorne, CAExec · DirectorScott Hirsch · Morristown, NJDirectorPaul Efron · Boston, MADirectorPaul Herendeen · Malvern, PADirectorMarc Yoskowitz · Malvern, PADirectorBlaise Coleman · Malvern, PAExec · DirectorSophia Langlois · Malvern, PADirectorAndy Pasternak · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗